@col69
Transferring the block parcel to a more motivated and strategically aligned investor who has regenerative medicine at its core would be better for Mesoblast.
Being so far advanced in their field (early mover) they need Capital Alliances and Partnerships to take advantage of this.
Bring on the News!
Cell Therapy News/Articles, page-77
-
- There are more pages in this discussion • 18,188 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.46 |
Change
-0.050(3.31%) |
Mkt cap ! $1.681B | |||
| Open | High | Low | Value | Volume |
| $1.45 | $1.50 | $1.45 | $6.766M | 4.616M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 21 | 11510 | $1.46 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.47 | 44125 | 21 |
View Market Depth
| Last trade - 15.26pm 08/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |